Your browser doesn't support javascript.
loading
Absorption, disposition and metabolic pathway of amiselimod (MT-1303) in healthy volunteers in a mass balance study.
Kifuji, Takayuki; Inoue, Shinsuke; Furukawa, Megumi; Perez Madera, Begonya; Goto, Takahiro; Kumagai, Hiroshi; Mair, Stuart J; Kawaguchi, Atsuhiro.
Afiliação
  • Kifuji T; a Data Science Department, Ikuyaku. Integrated Value Development Division , Mitsubishi Tanabe Pharma Corporation , Chuo-ku , Tokyo , Japan.
  • Inoue S; a Data Science Department, Ikuyaku. Integrated Value Development Division , Mitsubishi Tanabe Pharma Corporation , Chuo-ku , Tokyo , Japan.
  • Furukawa M; a Data Science Department, Ikuyaku. Integrated Value Development Division , Mitsubishi Tanabe Pharma Corporation , Chuo-ku , Tokyo , Japan.
  • Perez Madera B; b Mitsubishi Tanabe Pharma Europe Ltd. , London , UK.
  • Goto T; c DMPK Research Laboratories, Sohyaku. Innovative Research Division , Mitsubishi Tanabe Pharma Corporation , Yokohama , Kanagawa , Japan.
  • Kumagai H; c DMPK Research Laboratories, Sohyaku. Innovative Research Division , Mitsubishi Tanabe Pharma Corporation , Yokohama , Kanagawa , Japan.
  • Mair SJ; d Quotient Sciences , Nottingham , UK.
  • Kawaguchi A; a Data Science Department, Ikuyaku. Integrated Value Development Division , Mitsubishi Tanabe Pharma Corporation , Chuo-ku , Tokyo , Japan.
Xenobiotica ; 49(9): 1033-1043, 2019 Sep.
Article em En | MEDLINE | ID: mdl-30231665

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propanolaminas Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propanolaminas Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article